These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38104333)

  • 21. Locoregional recurrence of breast cancer presenting as upper limb venous thromboembolism.
    Sayers A; Hope C; Lingam KM
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary bladder metastases from breast carcinoma.
    Haid M; Ignatoff J; Khandekar JD; Graham J; Holland J
    Cancer; 1980 Jul; 46(1):229-32. PubMed ID: 7388764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
    Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
    Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late urinary bladder metastasis from breast cancer.
    De Rose AF; Balzarini F; Mantica G; Toncini C; Terrone C
    Arch Ital Urol Androl; 2019 Mar; 91(1):60-62. PubMed ID: 30932435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
    Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
    Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer.
    Grova MM; Strassle PD; Navajas EE; Gallagher KK; Ollila DW; Downs-Canner SM; Spanheimer PM
    Ann Surg Oncol; 2021 Apr; 28(4):2182-2190. PubMed ID: 32974693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer.
    Hirko KA; Regan MM; Remolano MC; Schlossman J; Harrison B; Yeh E; Jacene H; Nakhlis F; Block C; Rosenbluth JM; Garrido-Castro AC; Overmoyer BA
    Am J Clin Oncol; 2021 Sep; 44(9):449-455. PubMed ID: 34149037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory breast cancer: a single centre analysis.
    Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
    Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An unusual "linitis plastica" like breast cancer bladder metastasis.
    Farci R; Tolu S; Trombetta M; Murgia A; Solinas A
    Arch Ital Urol Androl; 2024 Jun; 96(2):12483. PubMed ID: 38934524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience.
    Nakhlis F; Regan MM; Chun YS; Dominici LS; Caterson S; Bellon JR; Warren L; Yeh ED; Jacene HA; King TA; Overmoyer B
    Breast J; 2020 Mar; 26(3):384-390. PubMed ID: 31448540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of a Multidisciplinary Inflammatory Breast Cancer Program for Quality Improvement.
    Hussain MM; Ashley G; Daniel S; Sachin J; Amy K; Doreen A; Sasha B; Roman S; Ko Un P
    Clin Breast Cancer; 2023 Aug; 23(6):e354-e358. PubMed ID: 37301712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
    Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
    Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report of bilateral inflammatory breast cancer.
    Masannat YA; Peter M; Turton P; Shaaban AM
    Eur J Cancer Care (Engl); 2010 Jul; 19(4):558-60. PubMed ID: 19708943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late breast cancer metastasis to the urinary bladder presenting with bilateral hydronephrosis.
    Jordan LA; Green L
    Radiol Case Rep; 2018 Dec; 13(6):1238-1241. PubMed ID: 30258514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care.
    Simpson AB; McCray D; Wengler C; Crowe JP; Djohan R; Tendulkar R; O'Rourke C; Grobmyer SR; Valente SA
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):642-648. PubMed ID: 27638670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary T-cell lymphoma of the urinary bladder presenting with haematuria and hydroureteronephrosis.
    Wang L; Cao ZZ; Qi L
    J Int Med Res; 2011; 39(5):2027-32. PubMed ID: 22118008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons learned from an unusual case of inflammatory breast cancer.
    Harrison AM; Zendejas B; Ali SM; Scow JS; Farley DR
    J Surg Educ; 2012; 69(3):350-4. PubMed ID: 22483137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Breast; 2017 Oct; 35():48-54. PubMed ID: 28649032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression.
    Van Berckelaer C; Rypens C; van Dam P; Pouillon L; Parizel M; Schats KA; Kockx M; Tjalma WAA; Vermeulen P; van Laere S; Bertucci F; Colpaert C; Dirix L
    Breast Cancer Res; 2019 Feb; 21(1):28. PubMed ID: 30777104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.